Ampio Pharmaceuticals, Inc is a biotechnology business based in the US. Ampio Pharmaceuticals shares (AMPE) are listed on the NYSE MKT and all prices are listed in US Dollars. Ampio Pharmaceuticals employs 18 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Ampio Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AMPE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Ampio Pharmaceuticals stock price (NYSE MKT: AMPE)Use our graph to track the performance of AMPE stocks over time.
Ampio Pharmaceuticals shares at a glance
|Latest market close||$1.81|
|52-week range||$0.62 - $2.98|
|50-day moving average||$1.65|
|200-day moving average||$1.74|
|Wall St. target price||$4.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.01|
Buy Ampio Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Ampio Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Ampio Pharmaceuticals price performance over time
|1 week (2021-07-21)||N/A|
|1 month (2021-07-01)||7.10%|
|3 months (2021-04-30)||-2.16%|
|6 months (2021-01-28)||N/A|
|1 year (2020-07-28)||N/A|
|2 years (2019-07-28)||N/A|
|3 years (2018-07-28)||N/A|
|5 years (2016-07-28)||N/A|
Ampio Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-55.74%|
|Return on equity TTM||-153.24%|
|Market capitalisation||$281.5 million|
TTM: trailing 12 months
Shorting Ampio Pharmaceuticals shares
There are currently 25.4 million Ampio Pharmaceuticals shares held short by investors – that's known as Ampio Pharmaceuticals's "short interest". This figure is 19.9% up from 21.2 million last month.
There are a few different ways that this level of interest in shorting Ampio Pharmaceuticals shares can be evaluated.
Ampio Pharmaceuticals's "short interest ratio" (SIR)
Ampio Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Ampio Pharmaceuticals shares currently shorted divided by the average quantity of Ampio Pharmaceuticals shares traded daily (recently around 3.0 million). Ampio Pharmaceuticals's SIR currently stands at 8.36. In other words for every 100,000 Ampio Pharmaceuticals shares traded daily on the market, roughly 8360 shares are currently held short.
However Ampio Pharmaceuticals's short interest can also be evaluated against the total number of Ampio Pharmaceuticals shares, or, against the total number of tradable Ampio Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ampio Pharmaceuticals's short interest could be expressed as 0.13% of the outstanding shares (for every 100,000 Ampio Pharmaceuticals shares in existence, roughly 130 shares are currently held short) or 0.1397% of the tradable shares (for every 100,000 tradable Ampio Pharmaceuticals shares, roughly 140 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Ampio Pharmaceuticals.
Find out more about how you can short Ampio Pharmaceuticals stock.
Ampio Pharmaceuticals share dividends
We're not expecting Ampio Pharmaceuticals to pay a dividend over the next 12 months.
Have Ampio Pharmaceuticals's shares ever split?
Ampio Pharmaceuticals's shares were split on a 1:3 basis on 31 July 2008. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ampio Pharmaceuticals shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Ampio Pharmaceuticals shares which in turn could have impacted Ampio Pharmaceuticals's share price.
Ampio Pharmaceuticals share price volatility
Over the last 12 months, Ampio Pharmaceuticals's shares have ranged in value from as little as $0.6209 up to $2.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Ampio Pharmaceuticals's is 1.7427. This would suggest that Ampio Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Ampio Pharmaceuticals overview
Ampio Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development of immunology-based therapies for the treatment of prevalent inflammatory conditions in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-016, an intravenous treatment that is in Phase I/II clinical trial for COVID-19 patients with respiratory illness; and AP-014, an inhaled treatment that is in Phase I clinical trial for COVID-19 induced respiratory distress. The company is headquartered in Englewood, Colorado. .
Stocks similar to Ampio Pharmaceuticals
Ampio Pharmaceuticals in the news
Ampio Pharmaceuticals to Present at the American College of Toxicology 42nd Annual Meeting
Ampio Pharmaceuticals to Present at the American College of Toxicology 42nd Annual Meeting
Ampio Pharmaceuticals to Present at the 14th International Congress on Systemic Lupus Erythematosus (LUPUS 2021) & 6th International Congress on Controversies in Rheumatology and Autoimmunity (CORA)
Frequently asked questionsWhat percentage of Ampio Pharmaceuticals is owned by insiders or institutions?
Currently 7.182% of Ampio Pharmaceuticals shares are held by insiders and 20.879% by institutions. How many people work for Ampio Pharmaceuticals?
Latest data suggests 18 work at Ampio Pharmaceuticals. When does the fiscal year end for Ampio Pharmaceuticals?
Ampio Pharmaceuticals's fiscal year ends in December. Where is Ampio Pharmaceuticals based?
Ampio Pharmaceuticals's address is: 373 Inverness Parkway, Englewood, CO, United States, 80112 What is Ampio Pharmaceuticals's ISIN number?
Ampio Pharmaceuticals's international securities identification number is: US03209T1097 What is Ampio Pharmaceuticals's CUSIP number?
Ampio Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 03209T109
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert